U.S. FDA Nod for Obagi’s First Filler, Saypha MagIQ
The U.S. Food and Drug Administration (FDA) has approved Obagi saypha MagIQ injectable hyaluronic acid (HA) gel, the first intradermal filler product in the Obagi saypha collection for commercial use in the U.S. market.